nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—MMP2—cornea—ocular cancer	0.125	0.27	CbGeAlD
Captopril—MMP9—cornea—ocular cancer	0.108	0.235	CbGeAlD
Captopril—LTA4H—eye—ocular cancer	0.0216	0.0469	CbGeAlD
Captopril—LTA4H—retina—ocular cancer	0.0214	0.0464	CbGeAlD
Captopril—MMP2—eye—ocular cancer	0.0153	0.0333	CbGeAlD
Captopril—REN—epithelium—ocular cancer	0.0153	0.0331	CbGeAlD
Captopril—LTA4H—lymphoid tissue—ocular cancer	0.0152	0.033	CbGeAlD
Captopril—MMP2—retina—ocular cancer	0.0152	0.033	CbGeAlD
Captopril—MMP2—epithelium—ocular cancer	0.014	0.0304	CbGeAlD
Captopril—MMP9—eye—ocular cancer	0.0133	0.0289	CbGeAlD
Captopril—MMP9—epithelium—ocular cancer	0.0122	0.0265	CbGeAlD
Captopril—F2—eye—ocular cancer	0.0116	0.0252	CbGeAlD
Captopril—MMP2—lymphoid tissue—ocular cancer	0.0108	0.0234	CbGeAlD
Captopril—F2—epithelium—ocular cancer	0.0106	0.0231	CbGeAlD
Captopril—MMP9—lymphoid tissue—ocular cancer	0.0094	0.0204	CbGeAlD
Captopril—SLC15A1—epithelium—ocular cancer	0.00907	0.0197	CbGeAlD
Captopril—F2—lymphoid tissue—ocular cancer	0.0082	0.0178	CbGeAlD
Captopril—ACE—eye—ocular cancer	0.00711	0.0154	CbGeAlD
Captopril—MMP2—Direct p53 effectors—E2F3—ocular cancer	0.00697	0.0129	CbGpPWpGaD
Captopril—F2—Thrombin signalling through proteinase activated receptors (PARs)—GNAQ—ocular cancer	0.00689	0.0128	CbGpPWpGaD
Captopril—MMP9—Validated targets of C-MYC transcriptional activation—CDC25A—ocular cancer	0.00687	0.0128	CbGpPWpGaD
Captopril—MMP2—FOXM1 transcription factor network—CDK4—ocular cancer	0.00661	0.0123	CbGpPWpGaD
Captopril—ACE—epithelium—ocular cancer	0.0065	0.0141	CbGeAlD
Captopril—MMP2—Direct p53 effectors—TFDP1—ocular cancer	0.00648	0.012	CbGpPWpGaD
Captopril—MMP9—TWEAK Signaling Pathway—HDAC1—ocular cancer	0.00647	0.012	CbGpPWpGaD
Captopril—ACE—ACE Inhibitor Pathway—TGFB1—ocular cancer	0.00634	0.0118	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—E2F5—ocular cancer	0.00629	0.0117	CbGpPWpGaD
Captopril—MMP2—Regulation of nuclear beta catenin signaling and target gene transcription—HDAC1—ocular cancer	0.00589	0.0109	CbGpPWpGaD
Captopril—MMP2—Regulation of nuclear beta catenin signaling and target gene transcription—CCND2—ocular cancer	0.00589	0.0109	CbGpPWpGaD
Captopril—F2—PAR1-mediated thrombin signaling events—GNA11—ocular cancer	0.00585	0.0109	CbGpPWpGaD
Captopril—MMP2—FOXM1 transcription factor network—RB1—ocular cancer	0.00575	0.0107	CbGpPWpGaD
Captopril—REN—Metabolism of proteins—EIF1AX—ocular cancer	0.0057	0.0106	CbGpPWpGaD
Captopril—MMP9—LPA receptor mediated events—GNA11—ocular cancer	0.00551	0.0102	CbGpPWpGaD
Captopril—F2—PAR1-mediated thrombin signaling events—GNAQ—ocular cancer	0.00544	0.0101	CbGpPWpGaD
Captopril—MMP9—LPA receptor mediated events—GNAQ—ocular cancer	0.00512	0.00951	CbGpPWpGaD
Captopril—MMP2—ATF-2 transcription factor network—CDK4—ocular cancer	0.00504	0.00936	CbGpPWpGaD
Captopril—LTA4H—Metabolism—PSPH—ocular cancer	0.00503	0.00934	CbGpPWpGaD
Captopril—ACE—lymphoid tissue—ocular cancer	0.00501	0.0109	CbGeAlD
Captopril—MMP2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCND1—ocular cancer	0.00473	0.00878	CbGpPWpGaD
Captopril—REN—Metabolism of proteins—RPL39—ocular cancer	0.00455	0.00846	CbGpPWpGaD
Captopril—MMP2—ATF-2 transcription factor network—RB1—ocular cancer	0.00438	0.00814	CbGpPWpGaD
Captopril—MMP2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—EP300—ocular cancer	0.00435	0.00808	CbGpPWpGaD
Captopril—MMP2—FOXM1 transcription factor network—CCND1—ocular cancer	0.00427	0.00793	CbGpPWpGaD
Captopril—MMP2—FOXM1 transcription factor network—EP300—ocular cancer	0.00393	0.0073	CbGpPWpGaD
Captopril—MMP9—Validated targets of C-MYC transcriptional activation—CCND2—ocular cancer	0.0039	0.00724	CbGpPWpGaD
Captopril—MMP2—Syndecan-2-mediated signaling events—TGFB1—ocular cancer	0.00387	0.00718	CbGpPWpGaD
Captopril—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—HDAC1—ocular cancer	0.00386	0.00717	CbGpPWpGaD
Captopril—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—CCND2—ocular cancer	0.00386	0.00717	CbGpPWpGaD
Captopril—MMP2—Angiopoietin receptor Tie2-mediated signaling—CDKN1A—ocular cancer	0.00359	0.00667	CbGpPWpGaD
Captopril—MMP2—FOXM1 transcription factor network—MYC—ocular cancer	0.00343	0.00636	CbGpPWpGaD
Captopril—MMP2—ATF-2 transcription factor network—CCND1—ocular cancer	0.00325	0.00604	CbGpPWpGaD
Captopril—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCND1—ocular cancer	0.0031	0.00576	CbGpPWpGaD
Captopril—MMP2—Direct p53 effectors—E2F1—ocular cancer	0.0031	0.00575	CbGpPWpGaD
Captopril—MMP2—Syndecan-2-mediated signaling events—HRAS—ocular cancer	0.00304	0.00565	CbGpPWpGaD
Captopril—MMP2—ATF-2 transcription factor network—EP300—ocular cancer	0.003	0.00556	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—ID2—ocular cancer	0.00288	0.00535	CbGpPWpGaD
Captopril—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—EP300—ocular cancer	0.00285	0.0053	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—EIF1AX—ocular cancer	0.00283	0.00525	CbGpPWpGaD
Captopril—MMP2—Plasma membrane estrogen receptor signaling—HRAS—ocular cancer	0.00274	0.00509	CbGpPWpGaD
Captopril—MMP9—Validated targets of C-MYC transcriptional activation—CDK4—ocular cancer	0.00262	0.00486	CbGpPWpGaD
Captopril—MMP2—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—ocular cancer	0.00255	0.00474	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—EIF1AX—ocular cancer	0.00254	0.00472	CbGpPWpGaD
Captopril—ABCB1—retina—ocular cancer	0.00248	0.00538	CbGeAlD
Captopril—MMP9—Angiogenesis—AKT1—ocular cancer	0.00244	0.00453	CbGpPWpGaD
Captopril—MMP9—Syndecan-1-mediated signaling events—TGFB1—ocular cancer	0.00243	0.00451	CbGpPWpGaD
Captopril—MMP2—Plasma membrane estrogen receptor signaling—AKT1—ocular cancer	0.00242	0.0045	CbGpPWpGaD
Captopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CCND3—ocular cancer	0.0024	0.00445	CbGpPWpGaD
Captopril—MMP2—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—ocular cancer	0.00235	0.00436	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—E2F1—ocular cancer	0.00233	0.00432	CbGpPWpGaD
Captopril—ABCB1—epithelium—ocular cancer	0.00229	0.00496	CbGeAlD
Captopril—MMP2—Metabolism of proteins—RPL39—ocular cancer	0.00226	0.0042	CbGpPWpGaD
Captopril—MMP9—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—ocular cancer	0.00224	0.00416	CbGpPWpGaD
Captopril—MMP2—Direct p53 effectors—RB1—ocular cancer	0.00219	0.00408	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—CCND3—ocular cancer	0.00214	0.00398	CbGpPWpGaD
Captopril—MMP2—Angiopoietin receptor Tie2-mediated signaling—AKT1—ocular cancer	0.00207	0.00384	CbGpPWpGaD
Captopril—MMP2—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—ocular cancer	0.00205	0.0038	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—RPL39—ocular cancer	0.00203	0.00378	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—CDK2—ocular cancer	0.00201	0.00373	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—CDKN1B—ocular cancer	0.00195	0.00362	CbGpPWpGaD
Captopril—MMP2—LPA receptor mediated events—HRAS—ocular cancer	0.00192	0.00357	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—CDK4—ocular cancer	0.0019	0.00352	CbGpPWpGaD
Captopril—MMP2—Direct p53 effectors—MDM2—ocular cancer	0.00187	0.00347	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—CCND1—ocular cancer	0.00186	0.00346	CbGpPWpGaD
Captopril—F2—Angiopoietin receptor Tie2-mediated signaling—CDKN1A—ocular cancer	0.00182	0.00338	CbGpPWpGaD
Captopril—F2—G alpha (q) signalling events—GNA11—ocular cancer	0.0018	0.00335	CbGpPWpGaD
Captopril—MMP9—Plasma membrane estrogen receptor signaling—HRAS—ocular cancer	0.0018	0.00334	CbGpPWpGaD
Captopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—ocular cancer	0.00178	0.00331	CbGpPWpGaD
Captopril—ABCB1—lymphoid tissue—ocular cancer	0.00176	0.00382	CbGeAlD
Captopril—MMP9—AP-1 transcription factor network—EP300—ocular cancer	0.00171	0.00318	CbGpPWpGaD
Captopril—MMP2—LPA receptor mediated events—AKT1—ocular cancer	0.0017	0.00315	CbGpPWpGaD
Captopril—F2—G alpha (q) signalling events—GNAQ—ocular cancer	0.00168	0.00311	CbGpPWpGaD
Captopril—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—ocular cancer	0.00167	0.00311	CbGpPWpGaD
Captopril—MMP2—AGE/RAGE pathway—AKT1—ocular cancer	0.00165	0.00307	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—RB1—ocular cancer	0.00165	0.00306	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—ocular cancer	0.00161	0.003	CbGpPWpGaD
Captopril—MMP9—Endochondral Ossification—TGFB1—ocular cancer	0.0016	0.00297	CbGpPWpGaD
Captopril—MMP9—Plasma membrane estrogen receptor signaling—AKT1—ocular cancer	0.00159	0.00295	CbGpPWpGaD
Captopril—LTA4H—Metabolism—GNA11—ocular cancer	0.00158	0.00294	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—GNA11—ocular cancer	0.00158	0.00293	CbGpPWpGaD
Captopril—MMP2—Direct p53 effectors—CDKN1A—ocular cancer	0.00158	0.00293	CbGpPWpGaD
Captopril—MMP9—TWEAK Signaling Pathway—AKT1—ocular cancer	0.00156	0.00289	CbGpPWpGaD
Captopril—MMP9—Validated targets of C-MYC transcriptional activation—EP300—ocular cancer	0.00156	0.00289	CbGpPWpGaD
Captopril—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—ocular cancer	0.00154	0.00286	CbGpPWpGaD
Captopril—MMP2—Direct p53 effectors—EP300—ocular cancer	0.0015	0.00279	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—GNAQ—ocular cancer	0.0015	0.00279	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—MYC—ocular cancer	0.00149	0.00277	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—TGFB1—ocular cancer	0.00149	0.00277	CbGpPWpGaD
Captopril—LTA4H—Metabolism—GNAQ—ocular cancer	0.00147	0.00273	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—GNAQ—ocular cancer	0.00147	0.00272	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—EIF1AX—ocular cancer	0.00143	0.00266	CbGpPWpGaD
Captopril—MMP2—EPH-Ephrin signaling—HRAS—ocular cancer	0.00141	0.00262	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—CCND3—ocular cancer	0.00141	0.00261	CbGpPWpGaD
Captopril—MMP9—Validated targets of C-MYC transcriptional activation—MYC—ocular cancer	0.00136	0.00252	CbGpPWpGaD
Captopril—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—ocular cancer	0.00134	0.00249	CbGpPWpGaD
Captopril—F2—Platelet Aggregation (Plug Formation)—AKT1—ocular cancer	0.00133	0.00247	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—CDKN1B—ocular cancer	0.00129	0.00239	CbGpPWpGaD
Captopril—MMP9—FGF signaling pathway—AKT1—ocular cancer	0.00127	0.00237	CbGpPWpGaD
Captopril—MMP9—LPA receptor mediated events—HRAS—ocular cancer	0.00126	0.00234	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—TP53—ocular cancer	0.00123	0.00228	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—CCND1—ocular cancer	0.00123	0.00228	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—MDM2—ocular cancer	0.00122	0.00227	CbGpPWpGaD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.00119	0.0022	CbGpPWpGaD
Captopril—F2—FOXA2 and FOXA3 transcription factor networks—AKT1—ocular cancer	0.00116	0.00215	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—RPL39—ocular cancer	0.00115	0.00213	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.00113	0.00209	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—CDKN1B—ocular cancer	0.00111	0.00207	CbGpPWpGaD
Captopril—MMP9—Validated targets of C-MYC transcriptional activation—TP53—ocular cancer	0.00111	0.00207	CbGpPWpGaD
Captopril—MMP9—Endochondral Ossification—AKT1—ocular cancer	0.00111	0.00207	CbGpPWpGaD
Captopril—MMP9—LPA receptor mediated events—AKT1—ocular cancer	0.00111	0.00207	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.0011	0.00205	CbGpPWpGaD
Captopril—MMP9—AGE/RAGE pathway—AKT1—ocular cancer	0.00109	0.00202	CbGpPWpGaD
Captopril—MMP2—Direct p53 effectors—TP53—ocular cancer	0.00107	0.00199	CbGpPWpGaD
Captopril—F2—Angiopoietin receptor Tie2-mediated signaling—AKT1—ocular cancer	0.00105	0.00194	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—CDKN1A—ocular cancer	0.00103	0.00191	CbGpPWpGaD
Captopril—F2—Folate Metabolism—TP53—ocular cancer	0.000992	0.00184	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—MYC—ocular cancer	0.000983	0.00183	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—TGFB1—ocular cancer	0.000981	0.00182	CbGpPWpGaD
Captopril—MMP9—EPH-Ephrin signaling—HRAS—ocular cancer	0.000926	0.00172	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—CDK4—ocular cancer	0.000921	0.00171	CbGpPWpGaD
Captopril—MMP9—CXCR4-mediated signaling events—AKT1—ocular cancer	0.000895	0.00166	CbGpPWpGaD
Captopril—F2—Hemostasis—GNA11—ocular cancer	0.000814	0.00151	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—TP53—ocular cancer	0.000808	0.0015	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—TGFB1—ocular cancer	0.000785	0.00146	CbGpPWpGaD
Captopril—F2—Hemostasis—GNAQ—ocular cancer	0.000756	0.0014	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SAG—ocular cancer	0.000752	0.0014	CbGpPWpGaD
Captopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ocular cancer	0.000697	0.00129	CbGpPWpGaD
Captopril—F2—Cell surface interactions at the vascular wall—HRAS—ocular cancer	0.000686	0.00127	CbGpPWpGaD
Captopril—F2—Hemostasis—HDAC1—ocular cancer	0.000682	0.00127	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—HRAS—ocular cancer	0.00067	0.00124	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—E2F5—ocular cancer	0.000666	0.00124	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—E2F4—ocular cancer	0.000652	0.00121	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—RBL1—ocular cancer	0.000639	0.00119	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—GNA11—ocular cancer	0.000626	0.00116	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—CDK4—ocular cancer	0.000604	0.00112	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—AKT1—ocular cancer	0.000591	0.0011	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—GNAQ—ocular cancer	0.000582	0.00108	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SAG—ocular cancer	0.000581	0.00108	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—E2F3—ocular cancer	0.000554	0.00103	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—EP300—ocular cancer	0.000547	0.00102	CbGpPWpGaD
Captopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	0.000533	0.00099	CbGpPWpGaD
Captopril—LTA4H—Metabolism—EP300—ocular cancer	0.000529	0.000982	CbGpPWpGaD
Captopril—MMP2—Axon guidance—HRAS—ocular cancer	0.000525	0.000974	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TFDP1—ocular cancer	0.000515	0.000957	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—TGFB1—ocular cancer	0.000515	0.000956	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—GNA11—ocular cancer	0.000514	0.000955	CbGpPWpGaD
Captopril—F2—Signaling Pathways—E2F5—ocular cancer	0.000514	0.000954	CbGpPWpGaD
Captopril—F2—Signaling Pathways—E2F4—ocular cancer	0.000503	0.000935	CbGpPWpGaD
Captopril—F2—Signaling Pathways—RBL1—ocular cancer	0.000494	0.000917	CbGpPWpGaD
Captopril—F2—Hemostasis—CDK2—ocular cancer	0.000484	0.000898	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—EP300—ocular cancer	0.000482	0.000895	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—GNAQ—ocular cancer	0.000478	0.000888	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—TGFB1—ocular cancer	0.000476	0.000883	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—GNA11—ocular cancer	0.000467	0.000867	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.000463	0.00086	CbGpPWpGaD
Captopril—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—ocular cancer	0.00046	0.000854	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	0.000458	0.000851	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—GNAQ—ocular cancer	0.000434	0.000806	CbGpPWpGaD
Captopril—F2—Signaling Pathways—E2F3—ocular cancer	0.000428	0.000795	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.000425	0.00079	CbGpPWpGaD
Captopril—ALB—Metabolism—PSPH—ocular cancer	0.000416	0.000772	CbGpPWpGaD
Captopril—ALB—Platelet degranulation—TGFB1—ocular cancer	0.00041	0.000761	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MAML2—ocular cancer	0.000409	0.00076	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TFDP1—ocular cancer	0.000398	0.000739	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—TP53—ocular cancer	0.000394	0.000731	CbGpPWpGaD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—ocular cancer	0.000391	0.000725	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—HRAS—ocular cancer	0.000374	0.000695	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ocular cancer	0.000369	0.000685	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.000367	0.000681	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PSPH—ocular cancer	0.000364	0.000677	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—TGFB1—ocular cancer	0.000363	0.000674	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—EP300—ocular cancer	0.000359	0.000666	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—GNA11—ocular cancer	0.000357	0.000663	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.000347	0.000644	CbGpPWpGaD
Captopril—MMP9—Axon guidance—HRAS—ocular cancer	0.000344	0.000639	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PSPH—ocular cancer	0.000343	0.000638	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—GNAQ—ocular cancer	0.000332	0.000617	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—AKT1—ocular cancer	0.000331	0.000614	CbGpPWpGaD
Captopril—ALB—Hemostasis—GNA11—ocular cancer	0.000323	0.000599	CbGpPWpGaD
Captopril—LTA4H—Metabolism—AKT1—ocular cancer	0.00032	0.000593	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—AKT1—ocular cancer	0.000319	0.000592	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MAML2—ocular cancer	0.000316	0.000587	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—TGFB1—ocular cancer	0.000312	0.000579	CbGpPWpGaD
Captopril—ALB—Hemostasis—GNAQ—ocular cancer	0.0003	0.000557	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—HDAC1—ocular cancer	0.000299	0.000556	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—AKT1—ocular cancer	0.000291	0.000541	CbGpPWpGaD
Captopril—F2—Signaling Pathways—GNA11—ocular cancer	0.000276	0.000512	CbGpPWpGaD
Captopril—F2—Hemostasis—EP300—ocular cancer	0.000272	0.000505	CbGpPWpGaD
Captopril—ALB—Hemostasis—HDAC1—ocular cancer	0.000271	0.000502	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CDKN2B—ocular cancer	0.000268	0.000498	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000257	0.000477	CbGpPWpGaD
Captopril—F2—Signaling Pathways—GNAQ—ocular cancer	0.000256	0.000476	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—E2F1—ocular cancer	0.000246	0.000457	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—HRAS—ocular cancer	0.000246	0.000456	CbGpPWpGaD
Captopril—F2—Hemostasis—TGFB1—ocular cancer	0.000236	0.000439	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000235	0.000436	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HDAC1—ocular cancer	0.000231	0.000429	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000224	0.000416	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—AKT1—ocular cancer	0.000217	0.000403	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000217	0.000402	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CDKN2B—ocular cancer	0.000207	0.000385	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000206	0.000383	CbGpPWpGaD
Captopril—F2—Hemostasis—TP53—ocular cancer	0.000195	0.000361	CbGpPWpGaD
Captopril—ALB—Hemostasis—CDK2—ocular cancer	0.000192	0.000356	CbGpPWpGaD
Captopril—F2—Signaling Pathways—E2F1—ocular cancer	0.00019	0.000353	CbGpPWpGaD
Captopril—F2—Hemostasis—HRAS—ocular cancer	0.000186	0.000345	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	0.000182	0.000338	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.00018	0.000333	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000179	0.000333	CbGpPWpGaD
Captopril—F2—Hemostasis—AKT1—ocular cancer	0.000164	0.000305	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MDM2—ocular cancer	0.000149	0.000276	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000147	0.000274	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CDKN1B—ocular cancer	0.000136	0.000252	CbGpPWpGaD
Captopril—ALB—Metabolism—GNA11—ocular cancer	0.000131	0.000243	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CCND1—ocular cancer	0.00013	0.000241	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—AKT1—ocular cancer	0.000126	0.000235	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CDKN1A—ocular cancer	0.000125	0.000233	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000125	0.000231	CbGpPWpGaD
Captopril—ALB—Metabolism—GNAQ—ocular cancer	0.000122	0.000226	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—EP300—ocular cancer	0.000119	0.000222	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MDM2—ocular cancer	0.000115	0.000213	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GNA11—ocular cancer	0.000115	0.000213	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GNA11—ocular cancer	0.000108	0.000201	CbGpPWpGaD
Captopril—ALB—Hemostasis—EP300—ocular cancer	0.000108	0.0002	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—HRAS—ocular cancer	0.000107	0.000198	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GNAQ—ocular cancer	0.000107	0.000198	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CDKN1B—ocular cancer	0.000105	0.000195	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MYC—ocular cancer	0.000104	0.000193	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—AKT1—ocular cancer	0.000104	0.000193	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TGFB1—ocular cancer	0.000104	0.000193	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GNAQ—ocular cancer	0.0001	0.000187	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCND1—ocular cancer	0.0001	0.000186	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—EP300—ocular cancer	9.82e-05	0.000182	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CDKN1A—ocular cancer	9.69e-05	0.00018	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—AKT1—ocular cancer	9.43e-05	0.000175	CbGpPWpGaD
Captopril—ALB—Hemostasis—TGFB1—ocular cancer	9.38e-05	0.000174	CbGpPWpGaD
Captopril—F2—Signaling Pathways—EP300—ocular cancer	9.22e-05	0.000171	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TP53—ocular cancer	8.54e-05	0.000159	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—HRAS—ocular cancer	8.17e-05	0.000152	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MYC—ocular cancer	8.03e-05	0.000149	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TGFB1—ocular cancer	8.01e-05	0.000149	CbGpPWpGaD
Captopril—ALB—Hemostasis—TP53—ocular cancer	7.72e-05	0.000143	CbGpPWpGaD
Captopril—ALB—Hemostasis—HRAS—ocular cancer	7.38e-05	0.000137	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—AKT1—ocular cancer	7.21e-05	0.000134	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TP53—ocular cancer	6.6e-05	0.000122	CbGpPWpGaD
Captopril—ALB—Hemostasis—AKT1—ocular cancer	6.52e-05	0.000121	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HRAS—ocular cancer	6.31e-05	0.000117	CbGpPWpGaD
Captopril—F2—Signaling Pathways—AKT1—ocular cancer	5.57e-05	0.000103	CbGpPWpGaD
Captopril—ALB—Metabolism—EP300—ocular cancer	4.37e-05	8.12e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—EP300—ocular cancer	3.83e-05	7.11e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—EP300—ocular cancer	3.61e-05	6.7e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—AKT1—ocular cancer	2.64e-05	4.91e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—AKT1—ocular cancer	2.32e-05	4.3e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—AKT1—ocular cancer	2.18e-05	4.05e-05	CbGpPWpGaD
